Koyfin Home > Directory > Health Care > Amicus Therapeutics > Return on Equity %

Amicus Therapeutics Return on Equity % Chart (FOLD)

Amicus Therapeutics annual/quarterly Return on Equity % from 2007 to 2018.
  • Amicus Therapeutics Return on Equity % for the quarter ending September 09, 2018 was -130.88 a 44.52% decrease of -58.28 year over year
  • Amicus Therapeutics Return on Equity % for the last 12 months ending September 09, 2018 was -82.89 a 3.90% decrease of -3.23 year over year
  • Amicus Therapeutics Annual Return on Equity % for 2017 was -79.66 a 29.06% decrease of -23.15 from 2016
  • Amicus Therapeutics Annual Return on Equity % for 2016 was -56.51 a 0.52% decrease of -0.29 from 2015
  • Amicus Therapeutics Annual Return on Equity % for 2015 was -56.22 a -46.02% increase of 25.87 from 2014
Other Margins & Efficiency Metrics:
  • Amicus Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-208m a 36.06% decrease of -75m year over year
  • Amicus Therapeutics Return on Capital % for the quarter ending September 09, 2018 was -53.00 a 52.45% decrease of -27.80 year over year
View Chart On Koyfin

Quarterly FOLD Return on Equity % Data

09/2018-130.88
06/2018-45.65
03/2018-45.67
12/2017-72.61
09/2017-132.04
06/2017-66.66
03/2017-65.57
12/2016-67.34
09/2016-55.64
06/2016-63.23

Annual FOLD Return on Equity % Data

2017-79.66
2016-56.51
2015-56.22
2014-82.09
2013-103.74
2012-98.74
2011-93.97
2010-80.34
2009-9.19
2008-45.15